The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application

BMC Psychiatry

Volumn 12, Issue , 2012, Pages

  Palmier Claus, Jasper E ^a   Ainsworth, John ^a   Machin, Matthew ^a   Barrowclough, Cristine ^a   Dunn, Graham ^a   Barkus, Emma ^b   Rogers, Anne ^a   Wykes, Til ^c   Kapur, Shitij ^c   Buchan, Iain ^a   Salter, Emma ^a   Lewis, Shôn W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Ambulant; Assessment; Mobile phone; Psychosis; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AMBULATORY MONITORING; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DELUSION; DELUSIONAL DISORDER; DSM-IV; FEASIBILITY STUDY; FEMALE; HALLUCINATION; HOPELESSNESS; HUMAN; MALE; MOBILE PHONE; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOSIS; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SELF REPORT; SEMI STRUCTURED INTERVIEW; SUSPICIOUSNESS; TEST RETEST RELIABILITY; VALIDITY; CALGARY DEPRESSION SCALE; DEPRESSION; DISEASE SEVERITY; EXCITEMENT; GOLD STANDARD; HOSTILITY; INTERNAL CONSISTENCY; MOBILE APPLICATION; PSYCHOSOCIAL WITHDRAWAL; SYMPTOM ASSESSMENT;

EID: 84867462898     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-12-172     Document Type: Article

References (36)

1. Lewis SW, Buchanan R. Schizophrenia 2007, Oxford: Healthpress, 3.
2. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ 2007, 10:23.
3. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261.
4. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res 1990, 3:247-251. 10.1016/0920-9964(90)90005-R, 2278986.
5. Perkins DO, Wyatt RJ, Bartko JJ. Penny-wise and pound-foolish: the impact of measurement error on sample size requirements in clinical trials. Biol Psychiatry 2000, 47:762-766. 10.1016/S0006-3223(00)00837-4, 10773186.
6. Müller MJ, Szegedi A. Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials. J Clin Psychopharmacol 2002, 22:318. 10.1097/00004714-200206000-00013, 12006903.
7. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res 2004, 72:29-39. 10.1016/j.schres.2004.09.007, 15531405.
8. Drake RJ, Pickles A, Bentall RP, Kinderman P, Haddock G, Tarrier N, Lewis SW. The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med 2004, 34:285-292. 10.1017/S0033291703008821, 14982134.
9. Lincoln TM, Ziegler M, Lüllmann E, Müller MJ, Rief W. Can delusions be self-assessed? Concordance between self-and observer-rated delusions in schizophrenia. Psychiatry Res 2010, 178:249-254. 10.1016/j.psychres.2009.04.019, 20483172.
10. Hamera EK, Kraenzle Schneider J, Potocky M, Casebeer MA. Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders. Schizophr Res 1996, 19:213-219. 10.1016/0920-9964(95)00100-X, 8789920.
11. Liraud F, Droulout T, Parrot M, Verdoux H. Agreement between self-rated and clinically assessed symptoms in subjects with psychosis. J Nerv Ment Dis 2004, 192:352. 10.1097/01.nmd.000126702.30745.1d, 15126889.
12. Ben-Zeev D, Morris S, Swendsen J, Granholm E. Predicting the Occurrence, Conviction, Distress, and Disruption of Different Delusional Experiences in the Daily Life of People with Schizophrenia . Schizophr Bull 2011, 37(6):1248-1256. 10.1093/schbul/sbq041, 20427351.
13. Granholm E, Loh C, Swendsen J. Feasibility and validity of computerized ecological momentary assessment in schizophrenia. Schizophr Bull 2008, 34:507-514. 2632427, 17932087.
14. Ben-Zeev D, Ellington K, Swendsen J, Granholm E. Examining a cognitive model of persecutory ideation in the daily life of people with schizophrenia: a computerized experience sampling study. Schizophr Bull 2011, 37:1248-1256. 10.1093/schbul/sbq041, 20427351.
15. Swendsen J, Ben-Zeev D, Granholm E. Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. Am J Psychiatry 2011, 168:202-209. 10.1176/appi.ajp.2010.10030463, 21078705.
16. The Communications Market 2011, (August) [http://stakeholders.ofcom.org.uk/market-data-research/market-data/communications-market-reports/].
17. Yung AR, McGorry PD, McFarlane CA, Patton GC. The PACE Clinic: development of a clinical service for young people at high risk of psychosis. Australas Psychiatry 1995, 3:345-349.
18. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C. Mapping the onset of psychosis: the Comprehensive Assessment of At Risk Mental States. Aust N Z J Psychiatry 2005, 39:964-971. 10.1080/j.1440-1614.2005.01714.x, 16343296.
19. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry 2001, 58:1137. 10.1001/archpsyc.58.12.1137, 11735842.
20. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res 1992, 6:201-208. 10.1016/0920-9964(92)90003-N, 1571313.
21. Palmier-Claus S, Myin-Germeys I, Barkus E, Bentley L, Udachina A, Delespaul P, Lewis S, Dunn G. Experience sampling research in individuals with mental illness: reflections and guidance. Acta Psychiatr Scand 201, 123:12-20.
22. Appelbaum PS, Robbins PC, Roth LH. Dimensional approach to delusions: comparison across types and diagnoses. Am J Psychiatry 1999, 156:1938-1943.
23. Delespaul P. Assessing schizophrenia in daily life: The experience sampling method (pp. 65-67) 1995, Maastricht, the Netherlands: Universitaire Pers Maastricht.
24. StataCorporation Stata reference manual, release 10.0 2007, Stata Press: College Station, TX, StataCorporation.
25. SPSSInc SPSS 15.0 for Windows 2006, Chicago: SPSS Inc, SPSSInc.
26. Ebner-Priemer UW, Kuo J, Kleindienst N, Welch SS, Reisch T, Reinhard I, Lieb K, Linehan MM, Bohus M. State affective instability in borderline personality disorder assessed by ambulatory monitoring. Psychol Med 2007, 37:961-970. 10.1017/S0033291706009706, 17202005.
27. Palmier-Claus J, Taylor P, Gooding P, Dunn G, Lewis S. Affective variability predicts suicidal ideation in individuals at ultra-high risk of developing psychosis: An experience sampling study. Br J Clin Psychol 2012, 51:72-83. 10.1111/j.2044-8260.2011.02013.x, 22268542.
28. Wichers M, Simons CJP, Kramer IMA, Hartmann JA, Lothmann C, Myin-Germeys I, van Bemmel AL, Peeters F, Delespaul P, van Os J. Momentary assessment technology as a tool to help patients with depression help themselves. Acta Psychiatr Scand 2011, 124:262-272. 10.1111/j.1600-0447.2011.01749.x, 21838742.
29. Myin-Germeys I, Birchwood M, Kwapil T. From Environment to Therapy in Psychosis: A Real-World Momentary Assessment Approach. Schizophr Bull 2011, 37:244. 10.1093/schbul/sbq164, 3044621, 21224492.
30. Palmier Claus J. The clinical uses of momentary assessment. Acta Psychiatr Scand 2011, 124:241-242. 10.1111/j.1600-0447.2011.01761.x, 21916859.
31. Agid O, Kapur S, Arenovich T, Zipursky RB. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry 2003, 60:1228. 10.1001/archpsyc.60.12.1228, 14662555.
32. Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry 2005, 162:939-946. 10.1176/appi.ajp.162.5.939, 15863796.
33. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol 2010, 15:1-39. 10.1348/135910709X466063, 2800172, 19646331.
34. Kelly J, Gooding P, Pratt D, Ainsworth J, Welford M, Tarrier N. Intelligent Real Time Therapy (iRTT): Harnessing the power of machine learning to optimise the delivery of momentary cognitive-behavioural interventions. J Ment Health 21(4):404-414.
35. Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull 2012, 38(3):414-425. 10.1093/schbul/sbr155, 22080492.
36. Rogers A, Kirk S, Gately C, Mat CR, Finch T. Established users and the making of telecare work in long term condition management: implications for health policy. Soc Sci Med 2011, 72:1077-1184. 10.1016/j.socscimed.2011.01.031, 21397373.